We are pleased to announce that Memorial Hermann Health System and Quest Diagnostics are joining forces to broaden access to innovative, high-value lab services in Greater Houston.
Memorial Hermann and Quest have entered into a definitive agreement for Quest to acquire select assets which constitute substantially all the operations of Memorial Hermann Diagnostic Laboratories (MHDL). This includes more than 30 MHDL patient service centers and nearly 60 in-office laboratory services. Beginning Monday, Jan. 27, 2020, the acquisition of MHDL will undergo the customary regulatory and review processes. It is anticipated that, once customary regulatory approvals are given, the closing date may occur as early as Spring 2020, at which point the changes listed above will be effective.
There are no immediate changes to how Quest or Memorial Hermann laboratories will operate. Until the closing of the acquisition, and pending regulatory review, you should continue to interact with Quest and Memorial Hermann as you normally would.
As part of our commitment to lower the cost of care, we intend to utilize Quest’s expertise and scale to improve cost-efficiencies while maintaining high-quality services. As Memorial Hermann makes the shift toward value-based care, this agreement serves as a natural extension of our vision to create healthier communities and our strategy for the future—a future enabled by this new relationship and resources dedicated to these efforts.
Q: Why is Memorial Hermann joining forces with Quest Diagnostics?
A: Memorial Hermann is committed to delivering outstanding patient care with a vision to create healthier communities—a future enabled by this new relationship and resources dedicated to these efforts. As part of our System’s commitment to lower the cost of care, we intend to utilize Quest’s expertise and scale to improve cost-efficiencies while maintaining high-quality services.
Q: Why did Memorial Hermann select Quest for this relationship?
A: We selected Quest for this relationship after thoughtful consideration of the best options to meet the needs of our patients and families. Quest Diagnostics, which has laboratory outreach operations in Houston, is considered by many the leading provider of diagnostic information services, offering broad access and high-quality, innovative, cost-efficient services. According to Quest, the company annually serves one in three adult Americans and half the physicians and hospitals in the United States.
Q: Will Memorial Hermann Diagnostic Laboratories (MHDL) continue to operate after the acquisition is complete?
A: Upon closing, MHDL assets and operations will no longer operate under the MHDL name; assets and operations will transition to Quest.
Q: Where will testing be performed?
A: Upon the acquisition’s completion, laboratory services performed by the Memorial Hermann Diagnostic Laboratories business will transition to the Quest Diagnostics laboratory in Houston. We are in the early phases of this relationship.
Q: What else do these changes mean for me?
A: According to Quest, utilizing Quest’s services will provide you with several benefits, including:
Q: Will Memorial Hermann operate a new laboratory outreach division like MHDL?
A: No, there are no plans to operate a new laboratory outreach division.
Q: Who may I contact with questions?
A: Memorial Hermann, together with Quest, is committed to a smooth transition. We are in the early stages of this relationship. As we work through the transition process, more information, including any changes to overall processes, will be provided to you here on our website. Should you have any questions in the meantime, please email mhcommunications@memorialhermann.org.
For questions, please contact a Memorial Hermann patient access representative at (713) 222-CARE (2273).